{
    "2021-04-19": [
        [
            {
                "time": "",
                "original_text": "东吴证券---医药生物行业：第五批带量采购对恒瑞医药影响有限，仍坚定看好【行业研究】",
                "features": {
                    "keywords": [
                        "带量采购",
                        "恒瑞医药",
                        "医药生物行业",
                        "影响有限",
                        "坚定看好"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "晨会0419｜平静期主角转换提速",
                "features": {
                    "keywords": [
                        "晨会",
                        "平静期",
                        "主角转换",
                        "提速"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}